Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Microbiol Spectr ; 11(6): e0199723, 2023 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-37800951

RESUMO

IMPORTANCE: Brucella spp. are zoonotic pathogens that can affect both terrestrial and marine mammals. Brucella ceti has been identified in various cetacean species, but only one sequence type (ST27) has been reported in humans. However, it is important to conduct surveillance studies to better understand the impact of marine Brucella species on marine mammals, a typically understudied host group. Here, we describe a systemic infection by two related strains of Brucella pinnipedialis (ST25) in a couple of live-stranded bottlenose dolphins, with more severe lesions in the younger animal. Furthermore, B. pinnipedialis was first detected in milk from a female cetacean that stranded with its offspring. Our study reveals novel insights into the epidemiology and pathological consequences of B. pinnipedialis infections in cetaceans, emphasizing the crucial importance of ongoing surveillance and accurate diagnosis to understand the impact of this pathogen on marine mammal populations.


Assuntos
Golfinho Nariz-de-Garrafa , Brucella , Brucelose , Sepse , Animais , Humanos , Feminino , Brucelose/veterinária
2.
Front Vet Sci ; 10: 1323500, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38260206

RESUMO

Brucella ovis causes non-zoonotic ovine brucellosis of worldwide distribution and is responsible for important economic losses mainly derived from male genital lesions and reproductive fails. Studies about the virulence mechanisms of this rough species (lacking lipopolysaccharide O-chains) are underrepresented when compared to the main zoonotic Brucella species that are smooth (with O-chains). Zinc intoxication constitutes a defense mechanism of the host against bacterial pathogens, which have developed efflux systems to counterbalance toxicity. In this study, we have characterized three potential B. ovis zinc exporters, including the ZntA ortholog previously studied in B. abortus. Despite an in-frame deletion removing 100 amino acids from B. ovis ZntA, the protein retained strong zinc efflux properties. Only indirect evidence suggested a higher exporter activity for B. abortus ZntA, which, together with differences in ZntR-mediated regulation of zntA expression between B. ovis and B. abortus, could contribute to explaining why the ΔzntR mutant of B. abortus is attenuated while that of B. ovis is virulent. Additionally, B. ovis ZntA was revealed as a powerful cadmium exporter contributing to cobalt, copper, and nickel detoxification, properties not previously described for the B. abortus ortholog. Deletion mutants for BOV_0501 and BOV_A1100, also identified as potential zinc exporters and pseudogenes in B. abortus, behaved as the B. ovis parental strain in all tests performed. However, their overexpression in the ΔzntA mutant allowed the detection of discrete zinc and cobalt efflux activity for BOV_0501 and BOV_A1100, respectively. Nevertheless, considering their low expression levels and the stronger activity of ZntA as a zinc and cobalt exporter, the biological role of BOV_0501 and BOV_A1100 is questionable. Results presented in this study evidence heterogeneity among pathogenic Brucellae regarding zinc export and, considering the virulence of B. ovis ΔzntA, suggest that host-mediated zinc intoxication is not a relevant mechanism to control B. ovis infection.

3.
Vet Microbiol ; 233: 68-77, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31176415

RESUMO

Swine brucellosis due to Brucella suis biovar 2 (bv2) is enzootic in wild boar and hare in continental Europe and may cause major economic losses to the pig industry, mainly in free-ranged pig farms. The high nucleotide identity found among the B. suis biovar 2 isolates has long hindered the full understanding of the epidemiology and the phylogeography of the disease. Here, we used multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) and whole-genome analysis to identify single-nucleotide polymorphisms (SNPs) in order to gain insights from the largest B. suis bv2 dataset analyzed so far composed of domestic pigs and wildlife isolates collected throughout Europe since the 1970s. We found four major clades with a specific phylogeographic pattern. The Iberian clade contains isolates exclusively from the Iberian Peninsula. The Central European clade includes most isolates from France, Northern Italy, Switzerland and an important proportion of those of Northern Spain. The Eastern European clade clustered isolates from Croatia and Hungary mainly but also from areas of France, Germany, Italy and Poland. Finally, a separated Sardinian clade grouped three isolates from this island. At fine scale, MLVA demonstrated an endemic status of the infection in Europe and it allowed tracking a large outbreak formed by different farms from Spain linked to the same infection source. The whole genome SNP analysis showed that the strains form genetically distinct clades, shared between wild boar and pigs, in agreement with the MLVA clades. Interestingly, all hare isolates clustered together within two groups composed exclusively of wildlife isolates. Our results support the hypothesis that maintenance and spread of B. suis bv2 in Europe is a dynamic process linked to the natural expansion of wild boar as the main wild reservoir of the infection, while spread over long distances is found largely dependent on anthropogenic activities.


Assuntos
Animais Selvagens/microbiologia , Brucella suis/genética , Brucelose/veterinária , Sus scrofa/microbiologia , Doenças dos Suínos/epidemiologia , Animais , Técnicas de Tipagem Bacteriana , Brucella suis/isolamento & purificação , Brucelose/epidemiologia , Surtos de Doenças , Europa (Continente)/epidemiologia , Genótipo , Repetições Minissatélites , Tipagem de Sequências Multilocus , Filogenia , Filogeografia , Suínos/microbiologia , Doenças dos Suínos/transmissão , Sequenciamento Completo do Genoma
4.
Transbound Emerg Dis ; 66(1): 505-516, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30375177

RESUMO

Brucellosis is a worldwide zoonosis causing important economic loss and a public health problem. Small ruminants are the preferred hosts of Brucella melitensis and thus the main source of human infections. Effective control of sheep and goat brucellosis has been achieved in several countries through vaccination with the live-attenuated B. melitensis Rev1 vaccine. However, Rev1 induces a long-lasting serological response that hinders the differentiation between infected and vaccinated animals. A Rev1::gfp strain expressing constitutively the Green Fluorescent Protein (GFP) was built by stable insertion of a mini-Tn7-gfp in the glmS-recG non-codifying chromosomal region. An associated indirect ELISA-GFP was developed to identify anti-GFP antibodies in vaccinated animals. The resulting Rev1::gfp kept the biological properties of the Rev1 reference strain, including residual virulence and efficacy in mice, and was readily distinguished from Rev1 and other Brucella field strains by direct visualization under ultraviolet illumination, fluorescence microscopy and a multiplex PCR-GFP. The Rev1::gfp strain did not elicit anti-GFP antibodies itself in lambs but when applied in combination with recombinant GFP induced an intense and long-lasting (>9 months) anti-GFP serological response readily detectable by the ELISA-GFP. Overall, our results confirm that Rev1 GFP-tagging can be a suitable alternative for identifying vaccinated sheep in infected contexts.


Assuntos
Vacina contra Brucelose/administração & dosagem , Brucella melitensis/imunologia , Brucelose/veterinária , Proteínas de Fluorescência Verde/imunologia , Imunoglobulina G/sangue , Doenças dos Ovinos/prevenção & controle , Vacinação/veterinária , Animais , Vacina contra Brucelose/imunologia , Brucelose/imunologia , Brucelose/prevenção & controle , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Substâncias Luminescentes , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Microscopia de Fluorescência/veterinária , Ovinos , Doenças dos Ovinos/diagnóstico , Doenças dos Ovinos/imunologia , Vacinas Atenuadas/imunologia
5.
Vet Res ; 43: 31, 2012 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-22515195

RESUMO

The Extradomain A from fibronectin (EDA) has an immunomodulatory role as fusion protein with viral and tumor antigens, but its effect when administered with bacteria has not been assessed. Here, we investigated the adjuvant effect of EDA in mice immunizations against Salmonella enterica subspecies enterica serovar Enteritidis (Salmonella Enteritidis). Since lipopolysaccharide (LPS) is a major virulence factor and the LPS O-polysaccharide (O-PS) is the immunodominant antigen in serological diagnostic tests, Salmonella mutants lacking O-PS (rough mutants) represent an interesting approach for developing new vaccines and diagnostic tests to differentiate infected and vaccinated animals (DIVA tests). Here, antigenic preparations (hot-saline extracts and formalin-inactivated bacterins) from two Salmonella Enteritidis rough mutants, carrying either intact (SEΔwaaL) or deep-defective (SEΔgal) LPS-Core, were used in combination with EDA. Biotinylated bacterins, in particular SEΔwaaL bacterin, decorated with EDAvidin (EDA and streptavidin fusion protein) improved the protection conferred by hot-saline or bacterins alone and prevented significantly the virulent infection at least to the levels of live attenuated rough mutants. These findings demonstrate the adjuvant effect of EDAvidin when administered with biotinylated bacterins from Salmonella Enteritidis lacking O-PS and the usefulness of BEDA-SEΔwaaL as non-live vaccine in the mouse model.


Assuntos
Vacinas Bacterianas/imunologia , Fibronectinas/imunologia , Lipopolissacarídeos/imunologia , Salmonella enteritidis/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Vacinas Bacterianas/administração & dosagem , Vacinas Bacterianas/genética , Feminino , Fibronectinas/química , Lipopolissacarídeos/genética , Camundongos , Camundongos Endogâmicos BALB C , Estrutura Terciária de Proteína , Salmonella enteritidis/genética , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia
6.
Vaccine ; 30(15): 2564-9, 2012 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-22326778

RESUMO

The development of effective vaccines against HIV-1 infection constitutes one of the major challenges in viral immunology. One of the protein candidates in vaccination against this virus is p24, since it is a conserved HIV antigen that has cytotoxic and helper T cell epitopes as well as B cell epitopes that may jointly confer enhanced protection against infection when used in immunization-challenge approaches. In this context, the adjuvant effect of EDA (used as EDAp24 fusion protein) and poly(I:C), as agonists of TLR4 and TLR3, respectively, was assessed in p24 immunizations using a recombinant Listeria monocytogenes HIV-1 Gag proteins (Lm-Gag, where p24 is the major antigen) for challenge in mice. Immunization with EDAp24 fusion protein together with poly(I:C) adjuvant induced a specific p24 IFN-γ production (Th1 profile) as well as protection against a Lm-Gag challenge, suggesting an additive or synergistic effect between both adjuvants. The combination of EDA (as a fusion protein with the antigen, which may favor antigen targeting to dendritic cells through TLR4) and poly(I:C) could thus be a good adjuvant candidate to enhance the immune response against HIV-1 proteins and its use may open new ways in vaccine investigations on this virus.


Assuntos
Adjuvantes Imunológicos/farmacologia , Fibronectinas/farmacologia , Produtos do Gene gag/imunologia , Proteína do Núcleo p24 do HIV/imunologia , Poli I-C/farmacologia , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/química , Animais , Antígenos Virais/imunologia , Feminino , Fibronectinas/administração & dosagem , Fibronectinas/química , Proteína do Núcleo p24 do HIV/administração & dosagem , Proteína do Núcleo p24 do HIV/química , Imunidade Celular/imunologia , Listeria monocytogenes/imunologia , Listeriose/prevenção & controle , Camundongos , Camundongos Endogâmicos BALB C , Poli I-C/administração & dosagem , Poli I-C/química , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/imunologia
7.
Vaccine ; 26(21): 2562-9, 2008 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-18423950

RESUMO

The innocuousness of the Brucella melitensis Rev 1 live attenuated vaccine strain has never been fully assessed in rams. The immunopathological responses and the kinetics and distribution of the infection induced by this strain were determined after subcutaneous or conjunctival vaccination in both young (3-4 months old) and adult (12 months old) rams. At regular intervals after vaccination the animals were bled for serological studies, and slaughtered for both pathological and bacteriological examinations. The serological response after conjunctival inoculation was of lower intensity and duration than that induced subcutaneously, being the differences more evident in young rams. No genital lesions were produced and genital organs and accessory sexual glands were never found infected, being Rev 1 infection restricted to lymph nodes and spleen. Immunostained Rev 1 bacteria were located intracellularly in plasmablasts, dendritic follicular cells and macrophages in the target lymph nodes, in which cellular hyperplasia was the dominant pathological response. Subcutaneous vaccination induced a generalized infection by 2 weeks after vaccination, being then restricted to the prescapular target lymph node. Infection after conjunctival vaccination was less generalized, being restricted essentially to the cranial lymph nodes. Rev 1 infection was fully cleared by 3 months after vaccination in all animals. These results confirm the innocuousness of B. melitensis Rev 1 vaccine in rams.


Assuntos
Vacina contra Brucelose/efeitos adversos , Brucella melitensis/patogenicidade , Brucelose/microbiologia , Brucelose/patologia , Doenças dos Ovinos/microbiologia , Doenças dos Ovinos/patologia , Animais , Anticorpos Antibacterianos/sangue , Vacina contra Brucelose/imunologia , Brucella melitensis/imunologia , Brucelose/imunologia , Células Dendríticas Foliculares/microbiologia , Genitália Masculina/microbiologia , Genitália Masculina/patologia , Injeções Subcutâneas , Linfonodos/microbiologia , Linfonodos/patologia , Macrófagos/microbiologia , Masculino , Plasmócitos/microbiologia , Ovinos , Doenças dos Ovinos/imunologia , Baço/microbiologia , Baço/patologia , Vacinas Atenuadas/efeitos adversos , Vacinas Atenuadas/imunologia
8.
Vet Microbiol ; 115(1-3): 269-77, 2006 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-16530357

RESUMO

Swine brucellosis is caused by the biovars 1, 2 and 3 of Brucella suis the identification of which up to now relies on microbiological tests lacking adequate specificity together with time consuming and expensive molecular procedures. Based on sequence variation of the omp2b gene, we have developed a four primer set multiplex PCR assay that was tested for polymorphism analysis of B. suis biovars causing brucellosis in swine. The assay exploits the single nucleotide polymorphisms found in omp2b gene of B. suis reference biovars which are conserved in 43 B. suis field isolates from different geographic origins and hosts. Three specific amplification patterns (S1, S2 and S3) were obtained for reference strains of B. suis biovars 1, 2 and 3, respectively. However, some B. suis field isolates identified as biovars 2 or 3 according AMOS-PCR, PCR-RFLP of omp31 and omp2 genes and classical bacteriological methods, resulted also in S1 patterns, limiting the typing usefulness of the method.


Assuntos
Proteínas de Bactérias/genética , Brucella suis/genética , Brucelose/veterinária , Reação em Cadeia da Polimerase/veterinária , Polimorfismo Genético , Porinas/genética , Doenças dos Suínos/microbiologia , Sequência de Aminoácidos , Animais , Proteínas de Bactérias/química , Sequência de Bases , Brucella suis/classificação , Brucella suis/isolamento & purificação , Brucelose/diagnóstico , Brucelose/microbiologia , DNA Bacteriano/química , Amplificação de Genes , Dados de Sequência Molecular , Filogenia , Reação em Cadeia da Polimerase/métodos , Polimorfismo de Nucleotídeo Único , Porinas/química , Suínos , Doenças dos Suínos/diagnóstico
9.
Vaccine ; 24(15): 2910-6, 2006 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-16439039

RESUMO

The Brucella abortus S19 and RB51 strains are the most widely used live vaccines against bovine brucellosis. However, both can induce abortion and milk excretion, S19 vaccination interferes in serological tests, and RB51 is less effective. We have shown previously that a rough wbkAB. abortus mutant is attenuated and a better vaccine than RB51 in BALB/c mice, and that mutants in the two-component regulatory system bvrS/bvrR are markedly attenuated while keeping a smooth lipopolysaccharide (S-LPS). In this work, we tested whether simultaneous inoculation with live bvrS increases wbkA vaccine efficacy in mice. Even at high doses, the bvrS mutant was cleared much faster from spleens than the wbkA mutant. The splenic persistence of the wbkA mutant increased when inoculated along with the bvrS mutant, but also with inactivated bvrS cells or with purified B. abortus S-LPS, strongly suggesting that S-LPS in the bvrS mutant played a determinant role in the wbkA persistence. When inoculated alone, both mutants protected against virulent B. abortus but less than when inoculated simultaneously, and the protection afforded by the combination was better than that obtained with B. abortus S19. Increased protection was also obtained after simultaneous inoculation of the wbkA mutant and inactivated bvrS cells or purified S-LPS, showing again the role played by the S-LPS in the bvrS cells. In mice, the bvrS-wbkA combination induced an antibody response reduced with respect to B. abortus S19 vaccination. Thus, the simultaneous use of live bvrS and wbkA B. abortus mutants seems a promising approach to overcome the problems of the S19 andRB51 vaccines.


Assuntos
Proteínas de Bactérias/genética , Vacina contra Brucelose/imunologia , Brucella abortus/imunologia , Brucelose/prevenção & controle , Animais , Anticorpos Antibacterianos/sangue , Vacina contra Brucelose/administração & dosagem , Vacina contra Brucelose/isolamento & purificação , Brucella abortus/genética , Brucella abortus/patogenicidade , Contagem de Colônia Microbiana , Feminino , Lipopolissacarídeos/administração & dosagem , Lipopolissacarídeos/imunologia , Lipopolissacarídeos/isolamento & purificação , Camundongos , Camundongos Endogâmicos BALB C , Mutação , Baço/microbiologia , Baço/patologia , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/imunologia , Virulência/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA